The tyrosine kinase inhibitor cediranib blocks ligand-induced vascular endothelial growth factor receptor-3 activity and lymphangiogenesis

  1. Lookup NU author(s)
  2. Professor Steve Wedge
Author(s)Heckman CA, Holopainen T, Wirzenius M, Keskitalo S, Jeltsch M, Herttuala SY, Wedge SR, Jürgensmeier JM, Alitalo K
Publication type Article
JournalCancer Research
Year2008
Volume68
Issue12
Pages4754-4762
ISSN (print)0008-5472
ISSN (electronic)1538-7445
Full text for this publication is not currently held within this repository. Alternative links are provided below where available.
PublisherAmerican Association for Cancer Research
URLhttp://dx.doi.org/10.1158/0008-5472.CAN-07-5809
DOI10.1158/0008-5472.CAN-07-5809
Actions    Link to this publication